Implantable biosensor devices for monitoring cardiac marker molecules

• US 7,632,234 B2
• Filed: 08/29/2003
• Issued: 12/15/2009
• Est. Priority Date: 08/29/2003
• Status: Expired due to Fees

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Bennett, Tommy D., Yang, Zhongping, Manda, Ven
• Primary Examiner(s): Mallar; Patricia
• Assistant Examiner(s): Toth; Karen E
• Application Number:
  US10/652,837
• Publication Number:
  US 20050049472A1
• Time in Patent Office: 2,300 Days
• Field of Search: None
• US Class Current: 600/508
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14865 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
• CPC Class Codes: A61N 1/36514 controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by two or more physical parameters A61N1/36585

Abstract

An implantable biosensor system is disclosed for determining levels of cardiac markers in a patient to aid in the diagnosis, determination of the severity and management of cardiovascular diseases. The sensor includes nanowire sensor elements having a biological recognition element attached to a nanowire transducer that specifically binds to the cardiac marker being measured. Each of the sensor elements is associated with a protective member that prevents the sensor element from interacting with the surrounding environment. At a selected time, the protective member may be disabled, thereby allowing the sensor element to begin sensing signals within a living body.

Claims

1. An implantable sensor system for determining the presence or amount of an analyte in a patient, comprising:

a. a sensor element comprising a biological recognition element associated with a portion or portions of a transducer, the biological recognition element being capable of specifically binding to a substance in the patient in an amount related to the presence or amount of the substance, wherein the substance is BNP or a marker related to BNP, and wherein when the substance is bound to the biological recognition element a detectable signal is produced; and

b. a controller associated with the sensor element to measure the detectable signal and relate the amount of the detectable signal measured with the presence or amount of the substance present in the patient;

wherein the sensor element is adapted to be implanted within the intracardiac circulatory system of the patient'"'"'s heart and

wherein the controller is adapted to compare measured levels of the substance to preselected levels stored in the controller and the controller includes a circuit to vary the AV interval of a cardiac resynchronization therapy device in response to measured levels of the substance.

2. The implantable sensor system of claim 1, wherein the marker related to BNP is pre proBNP or NT pro BNP.

3. The implantable sensor system of claim 1, wherein the biological recognition element is mounted on a nanowire.

4. The implantable sensor system of claim 3, wherein the nanowire comprises a gated nanowire field effect transistor.

5. The implantable sensor system of claim 1, further including a control circuit coupled to the protective member to disable the protective member after the selectable time period.

6. The implantable sensor system of claim 1, wherein the biological recognition element is an antibody or portion of an antibody capable of binding to the analyte.

7. The implantable sensor system of claim 1, wherein the biological recognition element is capable of reversibly binding to the substance.

8. An implantable cardiac resynchronization therapy system, comprising:

a sensor element comprising a biological recognition element associated with a portion or portions of a transducer, the biological recognition element being capable of specifically binding to a substance in the patient in an amount related to the presence or amount of the substance, wherein the substance is BNP or a marker related to BNP, and wherein when the substance is bound to the biological recognition element a detectable signal is produced; and

a cardiac resynchronization therapy device comprising a controller associated with the sensor element to measure the detectable signal and relate the amount of the detectable signal measured with the presence or amount of substance present in the patient, the controller (i) being adapted to compare measured levels of the substance to preselected levels stored in the controller and (ii) including a circuit to vary the AV interval of the cardiac resynchronization therapy device in response to measured levels of the substance.

9. The system of claim 8, further comprising an intracardiac lead connectable to the cardiac resynchronization therapy device, wherein the sensor element is deployed on the lead.

10. The implantable sensor system of claim 8, further comprising a protective member located adjacent the sensor element to shield the biological recognition member from a surrounding environment for a selectable time period.

11. The implantable sensor system of claim 8, wherein the marker related to BNP is pre proBNP or NT pro BNP.

12. The implantable sensor system of claim 8, wherein the biological recognition element is mounted on a nanowire.

13. The implantable sensor system of claim 12, wherein the nanowire comprises a gated nanowire field effect transistor.

14. The implantable sensor system of claim 8, further including a control circuit coupled to the protective member to disable the protective member after the selectable time period.

15. The implantable sensor system of claim 8, wherein the biological recognition element is an antibody or portion of an antibody capable of binding to the analyte.

16. The implantable sensor system of claim 8, wherein the biological recognition element is capable of reversibly binding to the substance.

17. An implantable cardiac therapy system,

comprising:

a BNP sensor producing an output signal indicative of BNP level;

a cardiac therapy device providing ventricular pacing on expiration of AV intervals, comprising a memory for storing sensed levels of BNP and a controller including a circuit to optimize the AV intervals in response to increases in sensed levels of BNP.

18. The system of claim 17, wherein the controller is adapted to compare sensed levels of BNP to preselected levels stored in the controller and the controller includes a circuit to vary the AV intervals of the cardiac therapy device in response to sensed levels of BNP.

19. The system of claim 17, further comprising an intracardiac lead connectable to the cardiac therapy device, wherein the sensor is deployed on the lead.

20. The system of claim 17, further comprising a protective member located adjacent the sensor to shield the sensor from a surrounding environment for a selectable time period.

21. The implantable sensor system of claim 20, further including a control circuit coupled to the protective member to disable the protective member after the selectable time period.

22. The implantable system of claim 17, wherein the sensor is responsive to a marker related to BNP.

23. The implantable system of claim 22, wherein the sensor is responsive to pre proBNP or NT pro BNP.